SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing for COVID-19 with ...

WASHINGTON (AP) Â Speed and accuracy are key features when screening for coronavirus. Quidel Corp. is one of a handful of U.S. companies authorized to sell a rapid test for COVID-19, yielding results ...

Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...

The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...

Quidel Corporation QDEL is scheduled to report first-quarter 2022 results on May 4, after the closing bell. In the last-reported quarter, the company’s earnings of $7.29 per share surpassed the Zacks ...

Quidel's Q4 revenue and earnings dropped sharply from the prior-year period. However, the company's results topped consensus estimates. Quidel's future growth drivers include the U.S. launch of a new ...

(Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp for the first COVID-19 antigen test. The emergency use authorization was ...